Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
Saved in:
| Title: | Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease. |
|---|---|
| Authors: | Busnadiego, Idoia1 (AUTHOR), Abela, Irene A.1,2 (AUTHOR), Frey, Pascal M.2,3 (AUTHOR), Hofmaenner, Daniel A.4 (AUTHOR), Scheier, Thomas C.2 (AUTHOR), Schuepbach, Reto A.4 (AUTHOR), Buehler, Philipp K.4 (AUTHOR), Brugger, Silvio D.2 (AUTHOR) silvio.brugger@usz.ch, Hale, Benjamin G.1 (AUTHOR) silvio.brugger@usz.ch |
| Source: | PLoS Biology. 7/5/2022, Vol. 20 Issue 7, p1-16. 16p. 3 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 157822314 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Busnadiego%2C+Idoia%22">Busnadiego, Idoia</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abela%2C+Irene+A%2E%22">Abela, Irene A.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Frey%2C+Pascal+M%2E%22">Frey, Pascal M.</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hofmaenner%2C+Daniel+A%2E%22">Hofmaenner, Daniel A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scheier%2C+Thomas+C%2E%22">Scheier, Thomas C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schuepbach%2C+Reto+A%2E%22">Schuepbach, Reto A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Buehler%2C+Philipp+K%2E%22">Buehler, Philipp K.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brugger%2C+Silvio+D%2E%22">Brugger, Silvio D.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> silvio.brugger@usz.ch</i><br /><searchLink fieldCode="AR" term="%22Hale%2C+Benjamin+G%2E%22">Hale, Benjamin G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> silvio.brugger@usz.ch</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22PLoS+Biology%22">PLoS Biology</searchLink>. 7/5/2022, Vol. 20 Issue 7, p1-16. 16p. 3 Charts, 3 Graphs. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=157822314 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pbio.3001709 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 16 StartPage: 1 Titles: – TitleFull: Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Busnadiego, Idoia – PersonEntity: Name: NameFull: Abela, Irene A. – PersonEntity: Name: NameFull: Frey, Pascal M. – PersonEntity: Name: NameFull: Hofmaenner, Daniel A. – PersonEntity: Name: NameFull: Scheier, Thomas C. – PersonEntity: Name: NameFull: Schuepbach, Reto A. – PersonEntity: Name: NameFull: Buehler, Philipp K. – PersonEntity: Name: NameFull: Brugger, Silvio D. – PersonEntity: Name: NameFull: Hale, Benjamin G. IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 07 Text: 7/5/2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 15449173 Numbering: – Type: volume Value: 20 – Type: issue Value: 7 Titles: – TitleFull: PLoS Biology Type: main |
| ResultId | 1 |
